Revolution Medicines (RVMD) net assets (shareholders' equity)

Net assets · fiscal 2025
$1.63B

Revolution Medicines (RVMD) had net assets of $1.63B at the end of fiscal 2025 (December 31, 2025). That is 28.0% lower than the $2.27B of fiscal 2024. Figures as of 18 Nov 2026, 20:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$1.63B
Change on fiscal 2024
−28.0%
Growth, 5 years
+28.0% a year
Highest on record
$2.27Bfiscal 2024
Lowest on record
-$152.57Mfiscal 2019
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revolution Medicines net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 28.0% a year. Across the 8 fiscal years on record (2018–2025), the highest was $2.27B in fiscal 2024 and the lowest -$152.57M in fiscal 2019.

History · 8 fiscal years

Net assets by fiscal year

Revolution Medicines net assets (shareholders' equity), year by year

Revolution Medicines (RVMD) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$1.63B 28.0% down
2024$2.27B 24.0% up
2023$1.83B 166.5% up
2022$685.19M 13.7% up
2021$602.57M 26.9% up
2020$474.68M—
2019-$152.57M—
2018-$108.42M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Revolution Medicines and comparable companies
CompanyNet assetsFiscal year
BeOne Medicines ONC$4.36B2025
Waters WAT$2.56B2025
Natera NTRA$1.71B2025
IQVIA Holdings IQV$6.50B2025
Revolution Medicines RVMD$1.63B2025
Royalty Pharma RPRX$6.48B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVMD

Revolution Medicines, figure by figure

Revolution Medicines (RVMD) overview: price, valuation and scorecardAll health care companies by market value

Revolution Medicines net assets (shareholders' equity): questions and answers

What are Revolution Medicines's net assets?

Revolution Medicines (RVMD) had net assets of $1.63B at the end of fiscal 2025 (December 31, 2025). That is 28.0% lower than the $2.27B of fiscal 2024.

What is the growth rate of Revolution Medicines's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 28.0% a year.

What are the highest and lowest net assets figures on record for Revolution Medicines?

Across the 8 fiscal years on record (2018–2025), the highest was $2.27B in fiscal 2024 and the lowest -$152.57M in fiscal 2019.

How is Revolution Medicines's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Revolution Medicines it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/RVMD/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.